전체 논문 (21편 · 1/1)
-
Increased prevalence of morphometric vertebral fractures in patients with hypercalcitoninemia due to medullary thyroid carcinoma.
-
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study).
-
The diagnostic utility of SATB2 immunohistochemistry as an adjunct for differentiating osteogenic from non-osteogenic bone tumors: A systematic review and Meta-analysis.
-
METTL3-mediated m6A modification of circWDR85 drives breast cancer bone metastasis via the CKB/c-Jun axis.
-
Models of myeloma bone disease: In vivo and in vitro approaches.
-
Atypical femoral fracture with early PET/CT changes from denosumab for metastatic breast cancer and transition from denosumab to zoledronic acid.
-
Altered vertebral biomechanical properties in prostate cancer patients following androgen deprivation therapy.
-
Bone microarchitecture and strength in men with prostate cancer with and without prevalent vertebral fractures at the initiation of androgen deprivation therapy.
-
Superiority of Ga-DOTA-FAPI-04 PET/CT to F-FDG PET/CT in the evaluation of different cancers with bone metastases.
-
The microstructure of metastatic bone lesions suggests tumor mediated alterations in bone mineralization.
-
Muscle secreted factors enhance activation of the PI3K/Akt and β-catenin pathways in murine osteocytes.
-
Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats.
-
Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice.
-
Differential Effects of Neurectomy and Botox-induced Muscle Paralysis on Bone Phenotype and Titanium Implant Osseointegration.
-
Changes in mechanical loading affect arthritis-induced bone loss in mice.
-
Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
-
In vitro and in vivo studies using non-traditional bisphosphonates.
-
PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats.
-
A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia.
-
Immobilization and long-term recovery results in large changes in bone structure and strength but no corresponding alterations of osteocyte lacunar properties.
-
Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.